LitCovid-sample-Enju  

PMC:7205724 / 14223-16625 JSONTXT 22 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T98558 0-5 CD denotes 4.1.3
T38385 7-12 NN denotes Serum
T65035 13-17 IN denotes from
T20625 18-30 JJ denotes convalescent
T20197 31-35 NN denotes SARS
T37092 36-44 NNS denotes patients
T79043 46-53 CD denotes 4.1.3.1
T13076 55-65 NN denotes Hypothesis
T75604 65-66 -COLON- denotes :
T99993 67-75 NN denotes SARS-CoV
T3009 76-79 CC denotes and
T80950 80-89 NN denotes SARS-CoV2
T92082 90-93 VBP denotes are
T32575 94-101 RB denotes ideally
T79226 102-109 JJ denotes similar
T33377 110-112 IN denotes in
T59896 113-116 DT denotes the
T19520 117-126 NN denotes structure
T87934 127-130 CC denotes and
T72009 131-134 DT denotes the
T96172 135-139 NN denotes cell
T92132 140-145 NN denotes entry
T55153 146-154 NN denotes receptor
T65675 155-158 CC denotes and
T29199 159-167 NN denotes protease
T27640 168-176 NN denotes SARS-CoV
T74776 177-180 CC denotes and
T21368 181-190 NN denotes SARS-CoV2
T82506 191-196 NN denotes share
T68425 197-207 RB denotes absolutely
T18098 208-211 DT denotes the
T56482 212-216 JJ denotes same
T5709 217-225 NN denotes cleavage
T53777 226-235 NNS denotes junctions
T48942 235-236 -COMMA- denotes ,
T23620 237-243 RB denotes almost
T31417 244-247 DT denotes the
T14679 248-252 JJ denotes same
T16845 253-261 NN denotes sequence
T94095 262-263 -LRB- denotes (
T72721 263-265 CD denotes 96
T51290 265-266 NN denotes %
T3648 266-267 -RRB- denotes )
T81238 268-270 IN denotes of
T80974 271-276 PRP-DOLLAR- denotes their
T24041 277-281 JJ denotes main
T97737 282-290 NN denotes protease
T89215 290-291 -COMMA- denotes ,
T68838 292-293 DT denotes a
T10566 294-298 JJ denotes high
T25132 299-305 NN denotes degree
T56803 306-307 -LRB- denotes (
T85670 307-309 CD denotes 76
T72732 309-310 NN denotes %
T51047 310-311 -RRB- denotes )
T87365 312-314 IN denotes of
T31118 315-325 NN denotes similarity
T29516 326-328 IN denotes in
T55756 329-332 DT denotes the
T19117 333-338 JJ denotes amino
T38328 339-343 NN denotes acid
T71701 344-352 NN denotes sequence
T52612 353-355 IN denotes of
T55072 356-361 PRP-DOLLAR- denotes their
T61270 362-363 NN denotes S
T71641 364-371 NN denotes protein
T35396 371-372 -COMMA- denotes ,
T5992 373-374 DT denotes a
T7278 375-382 JJ denotes similar
T86199 383-386 NN denotes S2′
T47005 387-395 NN denotes cleavage
T82402 396-400 NN denotes site
T47763 400-401 -COMMA- denotes ,
T84821 402-403 DT denotes a
T82586 404-411 JJ denotes similar
T33761 412-420 NN denotes spectrum
T77477 421-423 IN denotes of
T52803 424-429 NNS denotes cells
T10303 430-434 PRP denotes they
T7764 435-438 MD denotes can
T28508 439-444 VB denotes enter
T62400 444-445 -COMMA- denotes ,
T63048 446-449 CC denotes and
T36374 450-453 DT denotes the
T14538 454-464 NN denotes similarity
T20437 465-467 IN denotes of
T68062 468-471 DT denotes the
T38190 472-476 JJS denotes most
T74458 477-485 NNS denotes residues
T87029 486-495 JJ denotes essential
T85323 496-499 IN denotes for
T99917 500-507 VBG denotes binding
T21537 508-512 NN denotes ACE2
T6014 513-514 -LRB- denotes [
T41035 514-516 CD denotes 16
T8340 516-517 -RRB- denotes ]
T30067 517-518 -COMMA- denotes ,
T62375 519-520 -LRB- denotes [
T93474 520-522 CD denotes 17
T91627 522-523 -RRB- denotes ]
T61038 523-524 -COMMA- denotes ,
T23050 525-526 -LRB- denotes [
T2153 526-528 CD denotes 18
T12115 528-529 -RRB- denotes ]
T92800 531-535 RB denotes Also
T47629 535-536 -COMMA- denotes ,
T61968 537-541 DT denotes both
T81337 542-544 IN denotes of
T3352 545-549 PRP denotes them
T94564 550-557 VBP denotes utilize
T79549 558-561 DT denotes the
T81034 562-566 JJ denotes same
T66440 567-573 NN denotes domain
T64350 574-576 IN denotes of
T84214 577-580 NN denotes S1B
T9559 581-583 TO denotes to
T41916 584-592 VB denotes interact
T92667 593-597 IN denotes with
T6335 598-601 DT denotes the
T19773 602-606 NN denotes ACE2
T62479 607-615 NN denotes receptor
T90671 617-624 RB denotes However
T39710 624-625 -COMMA- denotes ,
T81474 626-630 PRP denotes they
T56686 631-637 VBP denotes differ
T68640 638-640 IN denotes in
T87109 641-652 JJ denotes proteolytic
T98211 653-663 NN denotes processing
T71821 664-666 TO denotes to
T76662 667-671 DT denotes some
T50781 672-678 NN denotes degree
T10243 680-685 NN denotes Study
T47759 686-687 -LRB- denotes [
T98110 687-689 CD denotes 16
T87807 689-690 -RRB- denotes ]
T21860 691-693 IN denotes of
T41284 694-697 DT denotes the
T98832 698-703 JJ denotes human
T59673 704-713 JJ denotes embryonic
T56471 714-720 NN denotes kidney
T99239 721-722 -LRB- denotes (
T14503 722-725 NN denotes HEK
T28717 725-726 -RRB- denotes )
T37299 727-731 NN denotes cell
T7184 732-736 NN denotes line
T85187 736-737 -COMMA- denotes ,
T92189 738-743 NN denotes 293 T
T15543 743-744 -COMMA- denotes ,
T94164 745-748 VBZ denotes has
T43431 749-754 VBN denotes shown
T43613 755-759 IN denotes that
T18285 760-761 DT denotes a
T61673 762-768 NN denotes signal
T89124 769-772 IN denotes for
T39220 773-776 DT denotes the
T95765 777-779 NN denotes S2
T75829 780-787 NN denotes subunit
T59345 788-790 VBZ denotes is
T37161 791-798 JJ denotes present
T63565 799-801 IN denotes in
T66184 802-807 NNS denotes cells
T20519 808-818 VBN denotes inoculated
T83162 819-823 IN denotes with
T31219 824-832 NN denotes SARS-2-S
T44086 832-833 -COMMA- denotes ,
T88144 834-837 CC denotes but
T98702 838-841 RB denotes not
T7566 842-844 IN denotes in
T55250 845-850 NNS denotes cells
T72973 851-861 VBN denotes inoculated
T20341 862-866 IN denotes with
T62455 867-873 NN denotes SARS-S
T10680 875-878 CD denotes Two
T43316 879-883 JJ denotes main
T55924 884-893 NNS denotes proteases
T2463 894-897 IN denotes for
T44465 898-902 DT denotes both
T77880 903-909 NN denotes SARS-S
T81456 910-913 CC denotes and
T6788 914-922 NN denotes SARS-2-S
T40938 923-926 VBP denotes are
T56973 927-936 JJ denotes endosomal
T42812 937-945 NN denotes cysteine
T96337 946-955 VBZ denotes proteases
T16443 956-965 NN denotes cathepsin
T42466 966-967 NN denotes B
T71562 968-971 CC denotes and
T46478 972-973 NN denotes L
T46398 974-975 -LRB- denotes (
T65344 975-981 NN denotes CatB/L
T41087 981-982 -RRB- denotes )
T20678 983-986 CC denotes and
T62149 987-990 DT denotes the
T68064 991-1004 JJ denotes transmembrane
T32448 1005-1013 NN denotes protease
T6092 1013-1014 -COMMA- denotes ,
T91380 1015-1021 NN denotes serine
T21495 1022-1030 NN denotes 2TMPRSS2
T43810 1031-1032 -LRB- denotes [
T10431 1032-1034 CD denotes 16
T63388 1034-1035 -RRB- denotes ]
T22680 1037-1039 IN denotes In
T74423 1040-1045 NN denotes 293 T
T35266 1046-1051 NNS denotes cells
T64338 1052-1059 VBG denotes lacking
T10485 1060-1068 NN denotes 2TMPRSS2
T85298 1068-1069 -COMMA- denotes ,
T71577 1070-1078 VBG denotes blocking
T94566 1079-1085 NN denotes CatB/L
T53535 1086-1094 NN denotes activity
T97443 1095-1102 IN denotes through
T35988 1103-1113 VBG denotes increasing
T24686 1114-1117 DT denotes the
T21828 1118-1127 JJ denotes endosomal
T57882 1128-1130 NN denotes pH
T2438 1131-1133 IN denotes by
T55605 1134-1142 NN denotes ammonium
T50104 1143-1151 NN denotes chloride
T36913 1152-1157 MD denotes could
T77508 1158-1171 RB denotes significantly
T70941 1172-1177 VB denotes limit
T75185 1178-1181 DT denotes the
T35511 1182-1187 NN denotes entry
T1792 1188-1190 IN denotes of
T53436 1191-1195 CC denotes both
T60629 1196-1202 NN denotes SARS-S
T78080 1203-1206 CC denotes and
T63658 1207-1216 JJ denotes SARS-2-S.
T98368 1217-1219 IN denotes In
T93115 1220-1236 NN denotes TMPRSS2 + Caco-2
T76285 1237-1242 NNS denotes cells
T31590 1242-1243 -COMMA- denotes ,
T25862 1244-1247 DT denotes the
T10314 1248-1254 NN denotes effect
T77548 1255-1257 IN denotes of
T48002 1258-1266 NN denotes ammonium
T31059 1267-1275 NN denotes chloride
T96902 1276-1283 VBD denotes existed
T81416 1284-1286 TO denotes to
T58350 1287-1288 DT denotes a
T53199 1289-1295 JJR denotes lesser
T72133 1296-1302 NN denotes extent
T12695 1304-1305 DT denotes A
T69785 1306-1317 NN denotes combination
T73262 1318-1320 IN denotes of
T77261 1321-1329 NN denotes camostat
T41765 1330-1338 NN denotes mesylate
T55852 1338-1339 -COMMA- denotes ,
T81348 1340-1341 DT denotes a
T88599 1342-1349 NN denotes blocker
T30022 1350-1352 IN denotes of
T40170 1353-1360 NN denotes TMPRSS2
T89506 1360-1361 -COMMA- denotes ,
T96381 1362-1365 CC denotes and
T31415 1366-1371 NN denotes E-64d
T14631 1371-1372 -COMMA- denotes ,
T42969 1373-1375 DT denotes an
T53416 1376-1385 NN denotes inhibitor
T3946 1386-1388 IN denotes of
T26871 1389-1395 NN denotes CatB/L
T27079 1395-1396 -COMMA- denotes ,
T56133 1397-1404 VBD denotes yielded
T87218 1405-1408 DT denotes the
T70471 1409-1417 JJ denotes complete
T11646 1418-1428 NN denotes inhibition
T91858 1429-1431 IN denotes of
T75023 1432-1440 NN denotes SARS-2-S
T21695 1441-1446 NN denotes entry
T17052 1447-1449 IN denotes in
T24463 1450-1466 NN denotes TMPRSS2 + Caco-2
T57029 1467-1472 NNS denotes cells
T57582 1474-1476 IN denotes In
T21513 1477-1481 CC denotes both
T67184 1482-1485 DT denotes the
T39137 1486-1491 JJ denotes human
T99828 1492-1496 NN denotes lung
T68094 1497-1503 NN denotes cancer
T76607 1504-1508 NN denotes cell
T55102 1509-1513 NN denotes line
T50829 1514-1520 NN denotes Calu-3
T53491 1521-1524 CC denotes and
T43867 1525-1528 DT denotes the
T21723 1529-1536 JJ denotes primary
T29104 1537-1542 JJ denotes human
T3411 1543-1547 NN denotes lung
T60390 1548-1553 NNS denotes cells
T81391 1553-1554 -COMMA- denotes ,
T33129 1555-1560 EX denotes there
T59040 1561-1564 VBD denotes was
T39475 1565-1566 DT denotes a
T15256 1567-1576 NN denotes reduction
T39714 1577-1579 IN denotes of
T49107 1580-1583 DT denotes the
T3461 1584-1589 NN denotes entry
T40063 1590-1592 IN denotes of
T3764 1593-1597 CC denotes both
T3726 1598-1604 NN denotes SARS-S
T74021 1605-1608 CC denotes and
T38308 1609-1617 NN denotes SARS-2-S
T3019 1618-1620 IN denotes by
T41127 1621-1629 NN denotes camostat
T6987 1630-1638 NN denotes mesylate
T21310 1638-1639 -COMMA- denotes ,
T88073 1640-1650 VBG denotes indicating
T47825 1651-1655 IN denotes that
T44262 1656-1662 NN denotes SARS-S
T25723 1663-1666 CC denotes and
T39073 1667-1675 NN denotes SARS-2-S
T85073 1676-1685 RB denotes partially
T75386 1686-1693 VBP denotes require
T13575 1694-1701 NN denotes TMPRSS2
T81091 1702-1705 IN denotes for
T10997 1706-1707 DT denotes a
T93402 1708-1712 NN denotes lung
T86423 1713-1722 NN denotes infection
T22068 1725-1732 CD denotes 4.1.3.2
T96302 1734-1742 NNP denotes Rational
T46108 1742-1743 -COLON- denotes :
T36509 1744-1749 NN denotes Serum
T11172 1750-1754 IN denotes from
T88528 1755-1767 JJ denotes convalescent
T76648 1768-1772 NN denotes SARS
T87601 1773-1781 NNS denotes patients
T31307 1782-1784 VBZ denotes is
T95865 1785-1789 JJ denotes able
T8130 1790-1792 TO denotes to
T87404 1793-1803 VB denotes neutralize
T83073 1804-1813 NN denotes SARS-CoV2
T56983 1814-1825 RB denotes efficiently
T85498 1826-1835 NN denotes Antiserum
T54727 1836-1840 WDT denotes that
T58025 1841-1849 VBZ denotes contains
T31794 1850-1860 NNS denotes antibodies
T72017 1861-1868 IN denotes against
T23410 1869-1874 JJ denotes human
T51011 1875-1879 NN denotes ACE2
T21969 1880-1885 MD denotes could
T10956 1886-1892 VB denotes hinder
T54161 1893-1896 DT denotes the
T78002 1897-1902 NN denotes entry
T48418 1903-1905 IN denotes of
T60794 1906-1910 CC denotes both
T68393 1911-1917 NN denotes SARS-S
T60207 1918-1921 CC denotes and
T37089 1922-1930 NN denotes SARS-2-S
T99631 1931-1942 NNS denotes pseudotypes
T70219 1943-1948 IN denotes while
T16218 1949-1952 RB denotes not
T76542 1953-1961 VBN denotes affected
T34278 1962-1965 DT denotes the
T2430 1966-1971 NN denotes entry
T98023 1972-1974 IN denotes of
T1819 1975-1980 NN denotes VSV-G
T13278 1981-1984 CC denotes and
T45315 1985-1991 NN denotes MERS-S
T32075 1992-2003 NNS denotes pseudotypes
T4602 2005-2007 PRP denotes It
T44962 2008-2016 VBZ denotes supports
T87111 2017-2020 DT denotes the
T50457 2021-2027 NN denotes notion
T41218 2028-2032 IN denotes that
T5721 2033-2039 NN denotes SARS-S
T21671 2040-2043 CC denotes and
T31105 2044-2052 NN denotes SARS-2-S
T49586 2053-2060 VBP denotes utilize
T31036 2061-2064 DT denotes the
T80074 2065-2069 JJ denotes same
T64684 2070-2077 JJ denotes primary
T36069 2078-2083 NN denotes entry
T27754 2084-2092 NN denotes receptor
T79207 2092-2093 -COMMA- denotes ,
T14629 2094-2098 FW denotes i.e.
T9665 2098-2099 -COMMA- denotes ,
T94116 2100-2104 NN denotes ACE2
T13974 2104-2105 -COMMA- denotes ,
T82487 2106-2111 WDT denotes which
T59931 2112-2114 VBZ denotes is
T21885 2115-2124 JJ denotes different
T2868 2125-2129 IN denotes from
T75369 2130-2133 DT denotes the
T44853 2134-2141 JJ denotes primary
T60868 2142-2151 NNS denotes receptors
T62157 2152-2157 NN denotes VSV-G
T53624 2158-2161 CC denotes and
T83630 2162-2168 NN denotes MERS-S
T67890 2169-2175 NN denotes engage
T48926 2176-2179 IN denotes for
T62543 2180-2184 NN denotes cell
T63733 2185-2190 NN denotes entry
T54619 2191-2195 WDT denotes that
T50860 2196-2198 VBZ denotes is
T99869 2199-2203 NN denotes LDLR
T6180 2204-2207 CC denotes and
T74051 2208-2212 NN denotes DPP4
T7846 2212-2213 -COMMA- denotes ,
T3162 2214-2226 RB denotes respectively
T66548 2228-2232 NN denotes Sera
T80239 2233-2237 IN denotes from
T68000 2238-2243 CD denotes three
T48403 2244-2256 JJ denotes convalescent
T51594 2257-2261 NN denotes SARS
T70519 2262-2270 NNS denotes patients
T59987 2271-2278 VBD denotes reduced
T66409 2279-2282 DT denotes the
T72671 2283-2289 JJ denotes SARS-S
T28601 2290-2295 NN denotes entry
T35673 2296-2299 CC denotes and
T3889 2299-2300 -COMMA- denotes ,
T61995 2301-2303 TO denotes to
T2565 2304-2305 VB denotes e
T43059 2306-2312 JJR denotes lesser
T78742 2313-2319 NN denotes degree
T89272 2319-2320 -COMMA- denotes ,
T22714 2321-2324 DT denotes the
T31064 2325-2333 NN denotes SARS-2-S
T32416 2334-2339 NN denotes entry
T56518 2341-2344 DT denotes The
T9724 2345-2352 NN denotes patient
T98703 2353-2358 NN denotes serum
T27055 2359-2365 NN denotes effect
T61320 2366-2369 VBD denotes was
T14991 2370-2372 IN denotes in
T7555 2373-2374 DT denotes a
T3238 2375-2389 JJ denotes dose-dependent
T1832 2390-2396 NN denotes manner
T4817 2397-2398 -LRB- denotes [
T18384 2398-2400 CD denotes 16
T62562 2400-2401 -RRB- denotes ]
R10115 T96902 T81416 arg1Of existed,to
R10122 T97737 T30067 arg1Of protease,","
R10836 T71701 T38328 arg1Of sequence,acid
R11446 T98211 T71821 arg1Of processing,to
R11531 T3352 T81337 arg2Of them,of
R11715 T78080 T98368 arg1Of and,In
R12595 T33761 T77477 arg1Of spectrum,of
R12626 T87404 T95865 arg2Of neutralize,able
R12822 T62157 T60868 arg1Of VSV-G,receptors
R12975 T85498 T10956 arg1Of Antiserum,hinder
R13076 T87601 T88528 arg1Of patients,convalescent
R13617 T60390 T21723 arg1Of cells,primary
R13635 T27754 T31036 arg1Of receptor,the
R13636 T99993 T3009 arg1Of SARS-CoV,and
R13660 T25132 T29516 arg1Of degree,in
R14196 T72973 T20341 arg1Of inoculated,with
R15037 T3648 T94095 arg3Of ),(
R15400 T2430 T34278 arg1Of entry,the
R15634 T50829 T76607 arg1Of Calu-3,cell
R16383 T42812 T56973 arg1Of cysteine,endosomal
R16425 T41765 T55852 arg1Of mesylate,","
R16622 T57029 T17052 arg2Of cells,in
R16643 T98211 T87109 arg1Of processing,proteolytic
R16681 T33761 T82586 arg1Of spectrum,similar
R16754 T72732 T85670 arg1Of %,76
R16949 T63658 T78080 arg2Of SARS-2-S.,and
R17401 T53416 T3946 arg1Of inhibitor,of
R17527 T71562 T20678 arg1Of and,and
R1755 T46478 T71562 arg2Of L,and
R17700 T50860 T3162 arg1Of is,respectively
R17724 T41916 T9559 arg1Of interact,to
R17912 T92189 T85187 arg2Of 293 T,","
R17963 T83162 T88144 arg1Of with,but
R18077 T74021 T3019 arg1Of and,by
R1825 T98110 T47759 arg2Of 16,[
R18378 T57882 T21828 arg1Of pH,endosomal
R18775 T82506 T23050 arg1Of share,[
R19016 T62562 T4817 arg3Of ],[
R19479 T50781 T71821 arg2Of degree,to
R19499 T27640 T74776 arg1Of SARS-CoV,and
R19622 T25132 T10566 arg1Of degree,high
R19625 T94564 T47629 arg1Of utilize,","
R20369 T75386 T47825 arg1Of require,that
R20386 T31219 T83162 arg2Of SARS-2-S,with
R20426 T63048 T62400 arg1Of and,","
R21351 T25132 T87365 arg1Of degree,of
R2145 T50829 T55102 arg1Of Calu-3,line
R21542 T61968 T81337 arg1Of both,of
R21546 T50104 T2438 arg2Of chloride,by
R21596 T35511 T75185 arg1Of entry,the
R22174 T82402 T86199 arg1Of site,S2′
R22357 T10956 T70219 arg1Of hinder,while
R22992 T14503 T99239 arg2Of HEK,(
R23171 T57882 T70941 arg1Of pH,limit
R23338 T7184 T21860 arg2Of line,of
R23414 T75829 T39220 arg1Of subunit,the
R23449 T3461 T39714 arg2Of entry,of
R23478 T60629 T78080 arg1Of SARS-S,and
R2373 T29199 T65675 arg2Of protease,and
R23772 T21537 T6014 arg1Of ACE2,[
R23798 T1819 T13278 arg1Of VSV-G,and
R23835 T26871 T3946 arg2Of CatB/L,of
R24598 T92082 T32575 arg1Of are,ideally
R25179 T38385 T65035 arg1Of Serum,from
R25449 T53777 T68425 arg1Of junctions,absolutely
R2570 T66184 T63565 arg2Of cells,in
R26368 T74776 T82506 arg1Of and,share
R26551 T71641 T61270 arg1Of protein,S
R26875 T27055 T9724 arg1Of effect,patient
R26919 T28601 T59987 arg2Of entry,reduced
R26981 T31105 T21671 arg2Of SARS-2-S,and
R27005 T7566 T88144 arg2Of in,but
R27054 T7184 T59673 arg1Of line,embryonic
R27124 T96902 T31590 arg1Of existed,","
R27614 T14538 T20437 arg1Of similarity,of
R27618 T32075 T98023 arg2Of pseudotypes,of
R27747 T94564 T92800 arg1Of utilize,Also
R27782 T5721 T21671 arg1Of SARS-S,and
R27865 T10314 T77548 arg1Of effect,of
R28065 T10303 T7764 arg1Of they,can
R28161 T38385 T98558 arg1Of Serum,4.1.3
R28208 T35511 T1792 arg1Of entry,of
R28299 T57882 T2438 arg1Of pH,by
R28408 T50457 T21885 arg1Of notion,different
R28577 T7184 T98832 arg1Of line,human
R28970 T61968 T94564 arg1Of both,utilize
R29294 T65344 T46398 arg2Of CatB/L,(
R29507 T50104 T55605 arg1Of chloride,ammonium
R29591 T53624 T2868 arg2Of and,from
R29995 T53777 T82506 arg2Of junctions,share
R30944 T42466 T16443 arg1Of B,cathepsin
R31098 T61673 T59345 arg1Of signal,is
R31293 T53535 T71577 arg2Of activity,blocking
R31390 T18384 T4817 arg2Of 16,[
R31601 T19520 T87934 arg1Of structure,and
R31772 T71701 T52612 arg1Of sequence,of
R31926 T15256 T39714 arg1Of reduction,of
R32051 T70519 T48403 arg1Of patients,convalescent
R32091 T45315 T13278 arg2Of MERS-S,and
R32128 T10303 T28508 arg1Of they,enter
R32244 T97737 T80974 arg1Of protease,their
R32288 T32416 T22714 arg1Of entry,the
R32534 T99917 T85323 arg2Of binding,for
R32622 T39073 T25723 arg2Of SARS-2-S,and
R33164 T28601 T66409 arg1Of entry,the
R33270 T62479 T19773 arg1Of receptor,ACE2
R33669 T85498 T54727 arg1Of Antiserum,that
R33918 T78742 T43059 arg1Of degree,lesser
R34331 T31059 T77548 arg2Of chloride,of
R35129 T57882 T24686 arg1Of pH,the
R35338 T21671 T49586 arg1Of and,utilize
R35498 T76285 T93115 arg1Of cells,TMPRSS2 + Caco-2
R36099 T65675 T92132 arg1Of and,entry
R3648 T16845 T94095 arg1Of sequence,(
R36526 T21885 T59931 arg2Of different,is
R37095 T70941 T36913 arg2Of limit,could
R37154 T50829 T21513 arg1Of Calu-3,both
R3726 T37161 T59345 arg2Of present,is
R37384 T81456 T44465 arg1Of and,both
R37625 T6987 T41127 arg1Of mesylate,camostat
R37635 T72133 T81416 arg2Of extent,to
R37669 T50457 T44962 arg2Of notion,supports
R37777 T10243 T94164 arg1Of Study,has
R38640 T65675 T96172 arg1Of and,cell
R38683 T97737 T89215 arg1Of protease,","
R38725 T50457 T59931 arg1Of notion,is
R38960 T78742 T2565 arg2Of degree,e
R39396 T87601 T11172 arg2Of patients,from
R39759 T71577 T97443 arg1Of blocking,through
R39883 T52803 T28508 arg2Of cells,enter
R40101 T35266 T22680 arg2Of cells,In
R4025 T88599 T81348 arg1Of blocker,a
R40491 T61673 T18285 arg1Of signal,a
R40823 T36509 T87404 arg1Of Serum,neutralize
R41008 T64338 T85298 arg1Of lacking,","
R41044 T51047 T56803 arg3Of ),(
R41530 T76285 T60629 arg1Of cells,SARS-S
R41959 T41765 T96381 arg1Of mesylate,and
R42092 T72133 T53199 arg1Of extent,lesser
R42203 T7184 T37299 arg1Of line,cell
R42254 T3009 T92082 arg1Of and,are
R42281 T76542 T70219 arg2Of affected,while
R42628 T99631 T37089 arg1Of pseudotypes,SARS-2-S
R42646 T93474 T62375 arg2Of 17,[
R42990 T33761 T84821 arg1Of spectrum,a
R43666 T57029 T24463 arg1Of cells,TMPRSS2 + Caco-2
R43699 T35266 T64338 arg1Of cells,lacking
R43951 T46478 T46398 arg1Of L,(
R44226 T72732 T56803 arg2Of %,(
R44438 T6788 T81456 arg2Of SARS-2-S,and
R44640 T10431 T43810 arg2Of 16,[
R45507 T59987 T61995 modOf reduced,to
R45763 T78080 T53436 arg1Of and,both
R45963 T31415 T96381 arg2Of E-64d,and
R46087 T61320 T4817 arg1Of was,[
R46099 T16845 T48942 arg2Of sequence,","
R46163 T50829 T68094 arg1Of Calu-3,cancer
R4625 T84214 T64350 arg2Of S1B,of
R46320 T13076 T79043 arg1Of Hypothesis,4.1.3.1
R46469 T15256 T39475 arg1Of reduction,a
R46721 T10314 T96902 arg1Of effect,existed
R47010 T74458 T38190 arg1Of residues,most
R4705 T13076 T75604 arg1Of Hypothesis,:
R47275 T55924 T10680 arg1Of proteases,Two
R47359 T86423 T81091 arg2Of infection,for
R47396 T4602 T44962 arg1Of It,supports
R47510 T82402 T63048 arg1Of site,and
R47877 T41916 T92667 arg1Of interact,with
R47881 T2153 T23050 arg2Of 18,[
R47891 T74458 T20437 arg2Of residues,of
R48042 T56686 T68640 arg1Of differ,in
R48104 T31794 T72017 arg1Of antibodies,against
R48113 T62455 T20341 arg2Of SARS-S,with
R48403 T66184 T20519 arg2Of cells,inoculated
R48454 T37092 T65035 arg2Of patients,from
R48533 T76542 T16218 arg1Of affected,not
R48722 T32448 T6092 arg1Of protease,","
R49023 T53624 T75369 arg1Of and,the
R49359 T20519 T7566 arg1Of inoculated,in
R49427 T44262 T25723 arg1Of SARS-S,and
R49758 T86423 T93402 arg1Of infection,lung
R49840 T63388 T43810 arg3Of ],[
R49876 T50457 T13974 arg1Of notion,","
R49926 T14538 T63048 arg2Of similarity,and
R49971 T55924 T2463 arg1Of proteases,for
R50036 T74458 T87029 arg1Of residues,essential
R50098 T55153 T65675 arg1Of receptor,and
R5011 T32075 T45315 arg1Of pseudotypes,MERS-S
R50111 T36509 T11172 arg1Of Serum,from
R50435 T72133 T58350 arg1Of extent,a
R50669 T66548 T59987 arg1Of Sera,reduced
R50675 T59040 T57582 arg1Of was,In
R50792 T63048 T35396 arg2Of and,","
R50831 T96302 T22068 arg1Of Rational,4.1.3.2
R50864 T31415 T14631 arg1Of E-64d,","
R51176 T88144 T44086 arg1Of but,","
R51417 T67890 T83630 arg1Of engage,MERS-S
R51607 T41916 T94564 arg3Of interact,utilize
R51750 T27055 T98703 arg1Of effect,serum
R51838 T13575 T75386 arg2Of TMPRSS2,require
R52514 T63733 T48926 arg2Of entry,for
R52768 T27754 T79207 arg1Of receptor,","
R52910 T75386 T88073 arg2Of require,indicating
R53418 T76285 T1792 arg2Of cells,of
R53466 T53491 T57582 arg2Of and,In
R53724 T27754 T36069 arg1Of receptor,entry
R53841 T76285 T63658 arg1Of cells,SARS-2-S.
R53920 T71641 T52612 arg2Of protein,of
R54048 T92082 T75604 arg2Of are,:
R55335 T60390 T29104 arg1Of cells,human
R55546 T49586 T41218 arg1Of utilize,that
R55603 T57882 T36913 arg1Of pH,could
R55692 T53416 T14631 arg2Of inhibitor,","
R56074 T71701 T19117 arg1Of sequence,amino
R56160 T70519 T51594 arg1Of patients,SARS
R56670 T96381 T89506 arg1Of and,","
R56677 T50829 T39137 arg1Of Calu-3,human
R56953 T87404 T56983 arg1Of neutralize,efficiently
R57053 T53416 T42969 arg1Of inhibitor,an
R57057 T27055 T14991 arg1Of effect,in
R57062 T36509 T31307 arg1Of Serum,is
R57112 T59987 T35673 arg1Of reduced,and
R57168 T77880 T81456 arg1Of SARS-S,and
R57198 T25723 T75386 arg1Of and,require
R57449 T16845 T23620 arg1Of sequence,almost
R57869 T96337 T43810 arg1Of proteases,[
R58115 T74051 T6180 arg2Of DPP4,and
R58146 T10243 T43431 arg1Of Study,shown
R58251 T82402 T47005 arg1Of site,cleavage
R5834 T63733 T62543 arg1Of entry,cell
R58356 T10243 T21860 arg1Of Study,of
R58389 T63733 T50860 arg1Of entry,is
R58480 T31794 T58025 arg2Of antibodies,contains
R58905 T37089 T60207 arg2Of SARS-2-S,and
R59126 T27754 T80074 arg1Of receptor,same
R59149 T88599 T30022 arg1Of blocker,of
R59330 T60390 T43867 arg1Of cells,the
R59565 T1832 T7555 arg1Of manner,a
R59867 T61673 T89124 arg1Of signal,for
R60172 T50829 T99828 arg1Of Calu-3,lung
R60201 T21537 T99917 arg2Of ACE2,binding
R60303 T71701 T55756 arg1Of sequence,the
R60630 T74458 T68062 arg1Of residues,the
R60648 T16845 T14679 arg1Of sequence,same
R60685 T32416 T89272 arg2Of entry,","
R60748 T11646 T91858 arg1Of inhibition,of
R60809 T85498 T58025 arg1Of Antiserum,contains
R60896 T32416 T31064 arg1Of entry,SARS-2-S
R61072 T88599 T55852 arg2Of blocker,","
R61217 T53624 T48926 arg1Of and,for
R61909 T3461 T40063 arg1Of entry,of
R62097 T59040 T21310 arg1Of was,","
R62130 T75829 T95765 arg1Of subunit,S2
R62417 T51290 T72721 arg1Of %,96
R62759 T81474 T56686 arg1Of they,differ
R62774 T66440 T79549 arg1Of domain,the
R62865 T50829 T67184 arg1Of Calu-3,the
R62931 T28717 T99239 arg3Of ),(
R63159 T75386 T81091 arg1Of require,for
R63165 T43431 T15543 arg1Of shown,","
R63232 T10956 T21969 arg2Of hinder,could
R6341 T70941 T77508 arg1Of limit,significantly
R63519 T56686 T90671 arg1Of differ,However
R63866 T35511 T70941 arg2Of entry,limit
R63867 T37161 T63565 arg1Of present,in
R64065 T99631 T60794 arg1Of pseudotypes,both
R64377 T55924 T40938 arg1Of proteases,are
R64570 T42466 T71562 arg1Of B,and
R64616 T3726 T74021 arg1Of SARS-S,and
R64712 T53777 T56482 arg1Of junctions,same
R64835 T67890 T53624 arg2Of engage,and
R64973 T80950 T3009 arg2Of SARS-CoV2,and
R6567 T79226 T33377 arg1Of similar,in
R65744 T35988 T97443 arg2Of increasing,through
R65884 T32075 T1819 arg1Of pseudotypes,VSV-G
R66257 T87807 T47759 arg3Of ],[
R66611 T70519 T80239 arg2Of patients,from
R66768 T11646 T70471 arg1Of inhibition,complete
R67933 T1832 T14991 arg2Of manner,in
R68217 T83073 T87404 arg2Of SARS-CoV2,neutralize
R68299 T91627 T62375 arg3Of ],[
R68308 T41087 T46398 arg3Of ),(
R68489 T27055 T56518 arg1Of effect,The
R68501 T15256 T59040 arg2Of reduction,was
R6883 T74021 T3764 arg1Of and,both
R68842 T37092 T20625 arg1Of patients,convalescent
R68983 T79226 T92082 arg2Of similar,are
R69132 T70519 T68000 arg1Of patients,three
R69283 T69785 T73262 arg1Of combination,of
R69371 T82402 T5992 arg1Of site,a
R69428 T65675 T87934 arg2Of and,and
R69633 T21695 T91858 arg2Of entry,of
R69901 T3009 T79226 arg1Of and,similar
R69904 T10314 T25862 arg1Of effect,the
R70728 T21695 T17052 arg1Of entry,in
R71267 T60390 T53491 arg2Of cells,and
R71489 T53777 T48942 arg1Of junctions,","
R71679 T41035 T6014 arg2Of 16,[
R71721 T21695 T75023 arg1Of entry,SARS-2-S
R71752 T53535 T94566 arg1Of activity,CatB/L
R7189 T1832 T3238 arg1Of manner,dose-dependent
R72431 T25132 T56803 arg1Of degree,(
R72554 T59345 T43431 arg2Of is,shown
R72699 T60390 T3411 arg1Of cells,lung
R72776 T7184 T85187 arg1Of line,","
R73092 T11646 T87218 arg1Of inhibition,the
R74735 T62479 T92667 arg2Of receptor,with
R75166 T81456 T2463 arg2Of and,for
R75542 T59987 T3889 arg1Of reduced,","
R75777 T51011 T23410 arg1Of ACE2,human
R75797 T95865 T31307 arg2Of able,is
R75974 T59040 T81391 arg1Of was,","
R76504 T69785 T56133 arg1Of combination,yielded
R76622 T36509 T95865 arg1Of Serum,able
R76746 T43431 T94164 arg2Of shown,has
R7678 T59345 T43613 arg1Of is,that
R76790 T82402 T47763 arg1Of site,","
R76876 T61673 T37161 arg1Of signal,present
R77219 T63733 T54619 arg1Of entry,that
R77322 T87934 T33377 arg2Of and,in
R77915 T87404 T8130 arg1Of neutralize,to
R77955 T56133 T27079 arg1Of yielded,","
R78407 T74021 T40063 arg2Of and,of
R78762 T21495 T91380 arg1Of 2TMPRSS2,serine
R79160 T50860 T7846 arg1Of is,","
R79215 T51290 T94095 arg2Of %,(
R79405 T2430 T76542 arg3Of entry,affected
R79812 T21368 T74776 arg2Of SARS-CoV2,and
R80027 T86423 T10997 arg1Of infection,a
R80079 T66440 T94564 arg2Of domain,utilize
R80207 T53777 T5709 arg1Of junctions,cleavage
R80345 T27754 T14629 arg1Of receptor,i.e.
R80403 T78002 T54161 arg1Of entry,the
R80643 T7184 T99239 arg1Of line,(
R80889 T85498 T76542 arg2Of Antiserum,affected
R81402 T27055 T61320 arg1Of effect,was
R81984 T97737 T81238 arg2Of protease,of
R83092 T7184 T56471 arg1Of line,kidney
R83097 T35266 T74423 arg1Of cells,293 T
R83284 T52803 T77477 arg2Of cells,of
R8336 T82402 T7278 arg1Of site,similar
R8345 T37092 T20197 arg1Of patients,SARS
R83525 T51011 T72017 arg2Of ACE2,against
R83550 T49586 T50457 arg2Of utilize,notion
R83600 T6987 T3019 arg2Of mesylate,by
R8489 T50781 T76662 arg1Of degree,some
R84898 T66548 T80239 arg1Of Sera,from
R84997 T32448 T68064 arg1Of protease,transmembrane
R85039 T31118 T87365 arg2Of similarity,of
R85149 T66440 T64350 arg1Of domain,of
R85170 T32448 T20678 arg2Of protease,and
R8551 T99869 T6180 arg1Of LDLR,and
R85515 T96381 T73262 arg2Of and,of
R85549 T50829 T53491 arg1Of Calu-3,and
R85999 T14991 T61320 arg2Of in,was
R86134 T62479 T6335 arg1Of receptor,the
R86136 T12115 T23050 arg3Of ],[
R86147 T97737 T24041 arg1Of protease,main
R86253 T66440 T81034 arg1Of domain,same
R86622 T28508 T7764 arg2Of enter,can
R87251 T62157 T53624 arg1Of VSV-G,and
R87272 T42812 T96337 arg1Of cysteine,proteases
R87525 T55924 T43316 arg1Of proteases,main
R87714 T25132 T89215 arg2Of degree,","
R87904 T11646 T56133 arg2Of inhibition,yielded
R88041 T14538 T36374 arg1Of similarity,the
R88130 T96902 T22680 arg1Of existed,In
R88200 T75386 T85073 arg1Of require,partially
R89371 T33761 T47763 arg2Of spectrum,","
R89421 T78002 T48418 arg1Of entry,of
R89636 T55250 T72973 arg2Of cells,inoculated
R90018 T94116 T9665 arg2Of ACE2,","
R9006 T3461 T49107 arg1Of entry,the
R90100 T55250 T7566 arg2Of cells,in
R90411 T56686 T39710 arg1Of differ,","
R9047 T87029 T85323 arg1Of essential,for
R90486 T87601 T76648 arg1Of patients,SARS
R90719 T21885 T2868 arg1Of different,from
R90752 T20678 T96337 arg2Of and,proteases
R90985 T70941 T35988 arg2Of limit,increasing
R91161 T65675 T72009 arg1Of and,the
R91188 T78002 T10956 arg2Of entry,hinder
R91466 T21495 T6092 arg2Of 2TMPRSS2,","
R91610 T10485 T64338 arg2Of 2TMPRSS2,lacking
R91702 T59040 T88073 modOf was,indicating
R92127 T62157 T44853 arg1Of VSV-G,primary
R9222 T50457 T82487 arg1Of notion,which
R92327 T2565 T61995 arg1Of e,to
R92376 T69785 T12695 arg1Of combination,A
R92582 T32448 T62149 arg1Of protease,the
R92599 T50457 T87111 arg1Of notion,the
R92749 T99631 T68393 arg1Of pseudotypes,SARS-S
R92776 T82506 T81238 arg1Of share,of
R92888 T53777 T18098 arg1Of junctions,the
R93097 T16845 T31417 arg1Of sequence,the
R93157 T2430 T98023 arg1Of entry,of
R9329 T7566 T98702 arg1Of in,not
R93335 T97737 T35396 arg1Of protease,","
R9363 T85498 T21969 arg1Of Antiserum,could
R93633 T75829 T89124 arg2Of subunit,for
R93750 T27754 T64684 arg1Of receptor,primary
R93897 T41765 T77261 arg1Of mesylate,camostat
R94510 T19520 T59896 arg1Of structure,the
R94590 T82506 T61038 arg1Of share,","
R94945 T33129 T59040 arg1Of there,was
R95003 T7184 T41284 arg1Of line,the
R95545 T25132 T68838 arg1Of degree,a
R95761 T78742 T89272 arg1Of degree,","
R95893 T71641 T55072 arg1Of protein,their
R96381 T98211 T68640 arg2Of processing,in
R96844 T28601 T72671 arg1Of entry,SARS-S
R9702 T27754 T9665 arg1Of receptor,","
R97711 T96302 T46108 arg1Of Rational,:
R97799 T20519 T83162 arg1Of inoculated,with
R97853 T6180 T50860 arg2Of and,is
R97859 T64338 T71577 modOf lacking,blocking
R9808 T71701 T29516 arg2Of sequence,in
R98234 T82506 T62375 arg1Of share,[
R98966 T40170 T30022 arg2Of TMPRSS2,of
R99271 T27754 T49586 arg2Of receptor,utilize
R99384 T10243 T47759 arg1Of Study,[
R99403 T38308 T74021 arg2Of SARS-2-S,and
R99421 T68393 T60207 arg1Of SARS-S,and
R9958 T8340 T6014 arg3Of ],[
R99617 T31059 T48002 arg1Of chloride,ammonium
R99688 T96337 T40938 arg2Of proteases,are
R99899 T99631 T48418 arg2Of pseudotypes,of